Upgrade to SI Premium - Free Trial

Myomo appoints Joseph Manko to board of directors

May 13, 2026 4:05 PM

Myomo Inc. (NYSE American: MYO) appointed Joseph M. Manko Jr. as a director effective May 9, 2026, to serve until the 2027 annual meeting of stockholders, according to a company statement. The appointment brings Myomo's board to seven directors.



Manko serves as Senior Principal of Horton Capital Management LLC, which the company describes as a significant shareholder. He founded The Horton Fund in 2013 and brings over 25 years of experience in investment banking, private equity, asset management and corporate strategy.



His background includes executive positions at BZ Fund Management, Deutsche Bank and Merrill Lynch, as well as work as a corporate finance attorney at Skadden, Arps, Slate, Meagher and Flom. Manko currently serves on the boards of Safeguard Scientifics and Koru Medical Systems. He previously served as a director on the boards of One Stop Systems, Creative Realities and Wireless Telecom Group.



"Through The Horton Fund, Joe has long been a steadfast investor and supporter for years," said Paul R. Gudonis, Chairman and Chief Executive Officer of Myomo. "He brings strong capital markets, strategic planning, and corporate governance experience to our Board."



Manko earned both his B.A. and Juris Doctor from the University of Pennsylvania. He expressed enthusiasm about joining the board during what he called "an important time in the Company's development."



Myomo develops wearable medical robotics technology for individuals with neurological disorders and upper-limb paralysis. The company's MyoPro product line consists of powered upper-limb orthoses designed to restore function to weakened or paralyzed arms.

Categories

Board Changes